Stocks and Investing Stocks and Investing
Wed, February 9, 2022
[ 12:00 AM ] - United States, WOPRAI
Sophie Karp Initiated (CEG) at Buy and Held Target at $51 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Rufus Hone Initiated (TPG) at Hold and Held Target at $34 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Macdonald Upgraded (THC) to Strong Buy and Held Target at $90 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sarah James Maintained (THC) at Buy with Increased Target to $99 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Pito Chickering Maintained (THC) at Strong Buy with Increased Target to $100 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Whit Mayo Upgraded (THC) to Buy and Increased Target to $100 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
A.J. Rice Maintained (THC) at Buy with Increased Target to $111 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Drew McReynolds Upgraded (TRI) to Buy and Decreased Target to $124 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Toni Kaplan Maintained (TRI) at Hold with Decreased Target to $112 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ravi Shanker Maintained (TFII) at Buy with Increased Target to $135 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ronald Epstein Maintained (TDY) at Strong Buy with Increased Target to $600 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kristine Liwag Maintained (TDG) at Buy with Increased Target to $801 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Seth Seifman Maintained (TDG) at Hold with Increased Target to $688 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Glass Maintained (SYY) at Hold with Increased Target to $86 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kelly Bania Maintained (SYY) at Buy and Held Target at $92 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Ivankoe Maintained (SYY) at Hold and Held Target at $85 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Saxon Maintained (AZTA) at Strong Buy with Decreased Target to $115 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Eric Beaumont Maintained (AWR) at Sell with Decreased Target to $86 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Eric Beaumont Maintained (AWK) at Hold with Decreased Target to $166 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brett Linzey Maintained (CARR) at Hold with Decreased Target to $50 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Walsh Maintained (CARR) at Hold with Decreased Target to $52 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Louis Miscioscia Upgraded (AMD) to Strong Buy and Increased Target to $150 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jay Olson Maintained (AMGN) at Buy with Increased Target to $285 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Carter Gould Maintained (AMGN) at Hold with Increased Target to $233 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mohit Bansal Maintained (AMGN) at Hold with Increased Target to $250 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (AMGN) at Hold with Increased Target to $238 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Justin Jenkins Maintained (BP) at Buy with Increased Target to $37 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tim Nollen Maintained (APPS) at Buy with Decreased Target to $70 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Courtney Yakavonis Maintained (AGCO) at Buy with Increased Target to $165 on, Feb 9th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jim Birchenough Maintained (ZYME) at Buy with Decreased Target to $48 on, Feb 9th, 2022

Jim Birchenough Maintained (ZYME) at Buy with Decreased Target to $48 on, Feb 9th, 2022


Published on 2024-10-27 19:37:10 - WOPRAI, Jim Birchenough
  Print publication without navigation


Jim Birchenough of Wells Fargo, Maintained "Zymeworks Inc." (ZYME) at Buy with Decreased Target from $56 to $48 on, Feb 9th, 2022.

Jim has made no other calls on ZYME in the last 4 months.



There are 2 other peers that have a rating on ZYME. Out of the 2 peers that are also analyzing ZYME, 0 agree with Jim's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jim

  • Andrew Berens of "SVB Leerink" Upgraded from Hold to Buy on, Friday, December 10th, 2021
  • David Novak of "Raymond James" Downgraded from Strong Buy to Buy and Held Target at $74 on, Friday, December 10th, 2021

Contributing Sources